{"title":"Understanding “Understanding”: An Important Step Toward Improving Informed Consent to Research","authors":"P. Appelbaum","doi":"10.1080/21507716.2010.499322","DOIUrl":null,"url":null,"abstract":"What is known about how well research subjects understand the information communicated to them during the informed consent process is not encouraging. Although there is some diversity in the literature, in general studies suggest that research subjects are unable to recall much—in many cases most—of the information that has been conveyed to them by researchers (Verheggen and Wijmen 1996). Subjects typically fail to grasp the purpose of research studies, the likelihood of benefit, and the range of risks (e.g., Daugherty et al. 2000). This has been found to be true for a broad array of research subjects suffering from a wide range of disorders. In addition to purely factual information about the study, which presents challenges of its own, subjects seem to have a particularly difficult time grasping some of the ways in which participation in a clinical trial differs from engaging in ordinary treatment (Appelbaum et al. 2004; Joffe et al. 2001). In this issue of AJOB Primary Research, Sand, Kassa, and Loge (2010) demonstrate the conceptual and methodological chaos of the literature on which these conclusions are based. Definitions of what is being measured are often imprecise and vary widely across studies. Subjects are interviewed at disparate time periods after passing through the consent process. Methods range from semi-structured interviews to structured questionnaires based on free response, yes/no, or multiple-choice approaches. Instruments are often developed ad hoc for each study, frequently with little effort at validation, and typically with questions specific to the context being assessed. Hence, few instruments are—or can be—used in more than a single study. Indeed, had Sand, Kassa, and Loge included a broader selection of studies in their review, including the large number that have involved what they term “vulnerable” and “normal” populations, it seems clear that even greater variation would have been apparent. That this is not a desirable situation seems indisputable. Although many questions come to mind, three force themselves to the front of the line: 1) What implications do these","PeriodicalId":89316,"journal":{"name":"AJOB primary research","volume":"2 1","pages":"1 - 3"},"PeriodicalIF":0.0000,"publicationDate":"2010-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJOB primary research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21507716.2010.499322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
Abstract
What is known about how well research subjects understand the information communicated to them during the informed consent process is not encouraging. Although there is some diversity in the literature, in general studies suggest that research subjects are unable to recall much—in many cases most—of the information that has been conveyed to them by researchers (Verheggen and Wijmen 1996). Subjects typically fail to grasp the purpose of research studies, the likelihood of benefit, and the range of risks (e.g., Daugherty et al. 2000). This has been found to be true for a broad array of research subjects suffering from a wide range of disorders. In addition to purely factual information about the study, which presents challenges of its own, subjects seem to have a particularly difficult time grasping some of the ways in which participation in a clinical trial differs from engaging in ordinary treatment (Appelbaum et al. 2004; Joffe et al. 2001). In this issue of AJOB Primary Research, Sand, Kassa, and Loge (2010) demonstrate the conceptual and methodological chaos of the literature on which these conclusions are based. Definitions of what is being measured are often imprecise and vary widely across studies. Subjects are interviewed at disparate time periods after passing through the consent process. Methods range from semi-structured interviews to structured questionnaires based on free response, yes/no, or multiple-choice approaches. Instruments are often developed ad hoc for each study, frequently with little effort at validation, and typically with questions specific to the context being assessed. Hence, few instruments are—or can be—used in more than a single study. Indeed, had Sand, Kassa, and Loge included a broader selection of studies in their review, including the large number that have involved what they term “vulnerable” and “normal” populations, it seems clear that even greater variation would have been apparent. That this is not a desirable situation seems indisputable. Although many questions come to mind, three force themselves to the front of the line: 1) What implications do these
在知情同意过程中,研究对象对传达给他们的信息的理解程度并不令人鼓舞。虽然文献中有一些差异,但一般研究表明,研究对象无法回忆起研究人员传达给他们的大部分信息,在许多情况下是大多数信息(Verheggen和Wijmen 1996)。受试者通常无法掌握研究的目的、获益的可能性和风险范围(例如,Daugherty et al. 2000)。对于患有各种各样的疾病的大量研究对象来说,这是正确的。除了关于研究的纯粹事实信息(这本身就存在挑战)之外,研究对象似乎特别难以掌握参与临床试验与参与普通治疗的一些不同之处(Appelbaum et al. 2004;Joffe et al. 2001)。在本期的《AJOB初级研究》中,Sand、Kassa和Loge(2010)展示了这些结论所依据的文献在概念和方法上的混乱。被测量的定义通常是不精确的,并且在不同的研究中差异很大。在通过同意程序后,受试者在不同的时间段接受采访。方法范围从半结构化访谈到基于自由回答、是/否或多项选择的结构化问卷。通常为每个研究开发专门的工具,通常很少进行验证,并且通常针对正在评估的背景提出特定的问题。因此,很少有仪器可以或可以用于不止一项研究。事实上,如果Sand, Kassa和Loge在他们的综述中纳入更广泛的研究选择,包括大量涉及他们所谓的“脆弱”和“正常”人群的研究,那么很明显,甚至更大的差异将是显而易见的。这不是一种令人满意的局面,这似乎是无可争辩的。尽管有许多问题浮现在脑海中,但有三个问题是最重要的:1)这些问题意味着什么